Literature DB >> 18591231

Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908.

Mélanie A M Cortes1, Julien Gibon, Nathalie K Chanteloup, Maryvonne Moulin-Schouleur, Philippe Gilot, Pierre Germon.   

Abstract

IbeA in extraintestinal pathogenic Escherichia coli (ExPEC) strains was previously described for its role in invasion. Here we investigated the role of IbeA and IbeT, encoded by a gene located downstream of ibeA, in the adhesion of the avian ExPEC strain BEN2908 to human brain microvascular endothelial cells (HBMEC). The DeltaibeA mutant was less adhesive to HBMEC than the wild-type strain BEN2908 was. Because strain BEN2908 also expresses type 1 fimbriae, we measured the adhesion specifically due to IbeA by comparing the adhesive properties of a Deltafim derivative of strain BEN2908 to those of a double Deltafim DeltaibeA mutant. No differences were observed, indicating that the reduction of adhesion in BEN2908 DeltaibeA could be due to a decrease in type 1 fimbria expression. We indeed showed that the decreased adhesion of BEN2908 DeltaibeA was correlated with a decrease in type 1 fimbria expression. Accordingly, more bacteria had a fim promoter orientated in the off position in a culture of BEN2908 DeltaibeA than in a culture of BEN2908. Expression of fimB and fimE, two genes encoding recombinases participating in controlling the orientation of the fim promoter, was decreased in BEN2908 DeltaibeA. A reduction of type 1 fimbria expression due to a preferential orientation of the fim promoter in the off position was also seen in an ibeT mutant of strain BEN2908. We finally suggest a role for IbeA and IbeT in modulating the expression of type 1 fimbriae through an as yet unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18591231      PMCID: PMC2519445          DOI: 10.1128/IAI.00334-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  A Rho-dependent phase-variable transcription terminator controls expression of the FimE recombinase in Escherichia coli.

Authors:  Susan A Joyce; Charles J Dorman
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

3.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  A novel genetic island of meningitic Escherichia coli K1 containing the ibeA invasion gene (GimA): functional annotation and carbon-source-regulated invasion of human brain microvascular endothelial cells.

Authors:  S H Huang; Y H Chen; G Kong; S H Chen; J Besemer; M Borodovsky; A Jong
Journal:  Funct Integr Genomics       Date:  2001-09       Impact factor: 3.410

5.  Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells.

Authors:  J Boudeau; N Barnich; A Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

6.  New human microvascular endothelial cell lines with specific adhesion molecules phenotypes.

Authors:  C Kieda; M Paprocka; A Krawczenko; P Załecki; P Dupuis; M Monsigny; C Radzikowski; D Duś
Journal:  Endothelium       Date:  2002

Review 7.  Virulence factors of Escherichia coli serotypes associated with avian colisepticaemia.

Authors:  R M La Ragione; M J Woodward
Journal:  Res Vet Sci       Date:  2002-08       Impact factor: 2.534

8.  Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease.

Authors:  Nicolas Barnich; Jérôme Boudeau; Laurent Claret; Arlette Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

9.  Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract.

Authors:  Farah K Bahrani-Mougeot; Eric L Buckles; C V Lockatell; J R Hebel; D E Johnson; C M Tang; M S Donnenberg
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

10.  Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off.

Authors:  Nereus W Gunther; Jennifer A Snyder; Virginia Lockatell; Ian Blomfield; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  21 in total

1.  Effects of ibeA deletion on virulence and biofilm formation of avian pathogenic Escherichia coli.

Authors:  Shaohui Wang; Chunling Niu; Zhenyu Shi; Yongjie Xia; Muhammad Yaqoob; Jianjun Dai; Chengping Lu
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  A metabolic operon in extraintestinal pathogenic Escherichia coli promotes fitness under stressful conditions and invasion of eukaryotic cells.

Authors:  Géraldine Rouquet; Gaëlle Porcheron; Claire Barra; Maryline Répérant; Nathalie K Chanteloup; Catherine Schouler; Philippe Gilot
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

3.  The Periplasmic Trehalase Affects Type 1 Fimbria Production and Virulence of Extraintestinal Pathogenic Escherichia coli Strain MT78.

Authors:  Daniel Brisotto Pavanelo; Sébastien Houle; Letícia Beatriz Matter; Charles Martin Dozois; Fabiana Horn
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

4.  Diagnostic strategy for identifying avian pathogenic Escherichia coli based on four patterns of virulence genes.

Authors:  Catherine Schouler; Brigitte Schaeffer; Annie Brée; Azucena Mora; Ghizlane Dahbi; François Biet; Eric Oswald; Jacques Mainil; Jorge Blanco; Maryvonne Moulin-Schouleur
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

5.  New role for the ibeA gene in H2O2 stress resistance of Escherichia coli.

Authors:  Maud Fléchard; Mélanie A M Cortes; Maryline Répérant; Pierre Germon
Journal:  J Bacteriol       Date:  2012-06-22       Impact factor: 3.490

6.  Sequencing and functional annotation of avian pathogenic Escherichia coli serogroup O78 strains reveal the evolution of E. coli lineages pathogenic for poultry via distinct mechanisms.

Authors:  Francis Dziva; Heidi Hauser; Thomas R Connor; Pauline M van Diemen; Graham Prescott; Gemma C Langridge; Sabine Eckert; Roy R Chaudhuri; Christa Ewers; Melha Mellata; Suman Mukhopadhyay; Roy Curtiss; Gordon Dougan; Lothar H Wieler; Nicholas R Thomson; Derek J Pickard; Mark P Stevens
Journal:  Infect Immun       Date:  2012-12-28       Impact factor: 3.441

7.  Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.

Authors:  Agnès Lefort; Xavière Panhard; Olivier Clermont; Paul-Louis Woerther; Catherine Branger; France Mentré; Bruno Fantin; Michel Wolff; Erick Denamur
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

8.  The GimA locus of extraintestinal pathogenic E. coli: does reductive evolution correlate with habitat and pathotype?

Authors:  Timo Homeier; Torsten Semmler; Lothar H Wieler; Christa Ewers
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

9.  Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82.

Authors:  Sylvie Miquel; Eric Peyretaillade; Laurent Claret; Amélie de Vallée; Carole Dossat; Benoit Vacherie; El Hajji Zineb; Beatrice Segurens; Valerie Barbe; Pierre Sauvanet; Christel Neut; Jean-Frédéric Colombel; Claudine Medigue; Francisco J M Mojica; Pierre Peyret; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

10.  Regulation of fim genes in uropathogenic Escherichia coli.

Authors:  William R Schwan
Journal:  World J Clin Infect Dis       Date:  2011-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.